When conventional treatment is not enough, new possibilities deserve the right expertise.
Some cancers require treatment beyond the conventional path.
When CAR-T Cell Therapy is recommended, patients and families are often introduced to an advanced and highly specialised form of treatment that can feel difficult to understand.
Shifara Health exists so that finding the right expertise, understanding the process and coordinating the journey around treatment never has to be something you navigate alone.
CAR-T Cell Therapy is an advanced form of cellular immunotherapy in which a patient’s T-cells are modified to recognise and target specific cancer cells.
The treatment involves specialised evaluation, cell collection and processing, preparation therapy and careful monitoring after the infusion.
Its suitability depends on the type of cancer, previous treatment history and individual clinical assessment by a specialised oncology team.
India is developing specialised cellular therapy capabilities, supported by experienced haemato-oncologists, advanced laboratories and dedicated treatment centres.
For eligible patients, access to specialised expertise and treatment options can be more accessible than in many other countries.
Shifara Health helps patients navigate the process from specialist consultation and report review to hospital coordination and post-treatment planning.
We review your diagnosis, pathology reports and previous treatment history and connect you with an appropriate haemato-oncology team.
Your specialist consultations and treatment assessments are already coordinated, helping you understand the next steps clearly.
CAR-T therapy involves multiple stages and close monitoring. We remain connected throughout your hospital journey and help coordinate communication and logistics around treatment.
Follow-up and monitoring are essential. We help coordinate post-treatment consultations, accommodation where required and return travel when medically appropriate.
We believe in transparency before commitment. The figures below are indicative starting points. Your Shifara Health advisor will share a personalised estimate based on your child’s diagnosis, donor match, transplant protocol, chosen hospital and individual care requirements.
| Treatment | Indicative Cost (USD) |
|---|---|
| CAR-T Cell Therapy (ALL) | $50,000 |
Note: All costs are indicative. A personalised estimate is part of your free consultation with Shifara Health.
Your conversations with Shifara Health are free of charge. And it is where the right questions can begin to find clearer answers.
No doctors found for this treatment.